These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16288750)

  • 1. High cholesterol diet induces tau hyperphosphorylation in apolipoprotein E deficient mice.
    Rahman A; Akterin S; Flores-Morales A; Crisby M; Kivipelto M; Schultzberg M; Cedazo-Mínguez A
    FEBS Lett; 2005 Nov; 579(28):6411-6. PubMed ID: 16288750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary cholesterol and its effect on tau protein: a study in apolipoprotein E-deficient and P301L human tau mice.
    Glöckner F; Meske V; Lütjohann D; Ohm TG
    J Neuropathol Exp Neurol; 2011 Apr; 70(4):292-301. PubMed ID: 21412171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau hyperphosphorylation in apolipoprotein E-deficient and control mice after closed head injury.
    Genis L; Chen Y; Shohami E; Michaelson DM
    J Neurosci Res; 2000 May; 60(4):559-64. PubMed ID: 10797559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade.
    Ohkubo N; Lee YD; Morishima A; Terashima T; Kikkawa S; Tohyama M; Sakanaka M; Tanaka J; Maeda N; Vitek MP; Mitsuda N
    FASEB J; 2003 Feb; 17(2):295-7. PubMed ID: 12490540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation state of tau in the hippocampus of apolipoprotein E4 and E3 knock-in mice.
    Kobayashi M; Ishiguro K; Katoh-Fukui Y; Yokoyama M; Fujita SC
    Neuroreport; 2003 Apr; 14(5):699-702. PubMed ID: 12692466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of tau in apolipoprotein E-deficient mice.
    Genis I; Gordon I; Sehayek E; Michaelson DM
    Neurosci Lett; 1995 Oct; 199(1):5-8. PubMed ID: 8584225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.
    Vega IE; Cui L; Propst JA; Hutton ML; Lee G; Yen SH
    Brain Res Mol Brain Res; 2005 Aug; 138(2):135-44. PubMed ID: 15913839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation.
    Xiong Y; Jing XP; Zhou XW; Wang XL; Yang Y; Sun XY; Qiu M; Cao FY; Lu YM; Liu R; Wang JZ
    Neurobiol Aging; 2013 Mar; 34(3):745-56. PubMed ID: 22892311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific dephosphorylation of tau of apolipoprotein E-deficient and control mice by M1 muscarinic agonist treatment.
    Genis I; Fisher A; Michaelson DM
    J Neurochem; 1999 Jan; 72(1):206-13. PubMed ID: 9886071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau pathology induces intraneuronal cholesterol accumulation.
    Glöckner F; Ohm TG
    J Neuropathol Exp Neurol; 2014 Sep; 73(9):846-54. PubMed ID: 25101701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E (ApoE) peptide regulates tau phosphorylation via two different signaling pathways.
    Wang X; Luebbe P; Gruenstein E; Zemlan F
    J Neurosci Res; 1998 Mar; 51(5):658-65. PubMed ID: 9512010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoE isoform- and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy.
    Seo DO; O'Donnell D; Jain N; Ulrich JD; Herz J; Li Y; Lemieux M; Cheng J; Hu H; Serrano JR; Bao X; Franke E; Karlsson M; Meier M; Deng S; Desai C; Dodiya H; Lelwala-Guruge J; Handley SA; Kipnis J; Sisodia SS; Gordon JI; Holtzman DM
    Science; 2023 Jan; 379(6628):eadd1236. PubMed ID: 36634180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and cognitive studies of apolipoprotein-E-deficient mice.
    Gordon I; Genis I; Grauer E; Sehayek E; Michaelson DM
    Mol Chem Neuropathol; 1996; 28(1-3):97-103. PubMed ID: 8871947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of apolipoprotein-E at an atypical protein kinase CK2 PSD/E site in vitro.
    Raftery M; Campbell R; Glaros EN; Rye KA; Halliday GM; Jessup W; Garner B
    Biochemistry; 2005 May; 44(19):7346-53. PubMed ID: 15882073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of tau protein is not affected in mice lacking apolipoprotein E.
    Mercken L; Brion JP
    Neuroreport; 1995 Nov; 6(17):2381-4. PubMed ID: 8747158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3R tau expression modifies behavior in transgenic mice.
    Shiryaev N; Jouroukhin Y; Gozes I
    J Neurosci Res; 2010 Sep; 88(12):2727-35. PubMed ID: 20544828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of tau phosphorylation in microtubule fractions by apolipoprotein E.
    Flaherty D; Lu Q; Soria J; Wood JG
    J Neurosci Res; 1999 May; 56(3):271-4. PubMed ID: 10336256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK).
    Yoshida H; Hastie CJ; McLauchlan H; Cohen P; Goedert M
    J Neurochem; 2004 Jul; 90(2):352-8. PubMed ID: 15228592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
    Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
    J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.